Login / Signup

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas.

Jean KimJu Hun OhHeather HarlemMichael D CullerCheol-Ryong KuEun Jig Lee
Published in: Endocrinology and metabolism (Seoul, Korea) (2021)
The novel chimeric molecule was effective in decreasing IGF-1 and GH levels and may serve as an effective therapeutic agent for acromegaly.
Keyphrases
  • growth hormone
  • cell therapy
  • cancer therapy
  • uric acid
  • stem cells
  • mesenchymal stem cells
  • metabolic syndrome
  • bone marrow
  • neuroendocrine tumors
  • cell proliferation
  • drug delivery
  • signaling pathway
  • prefrontal cortex